Geneticists develop novel gene therapy for glaucoma
tcd.ie
tcd.ie
The key paper was published in Science in 2017 by Pete Williams, Simon John and colleagues in mice.
https://pubmed.ncbi.nlm.nih.gov/28209901/
Vit B3 at relatively high dose (1 to 4 gm/day) is now being tested in several human clinical trials for glaucoma and other forms of neurodegenerative and neurocognitive age-related diseases.
See ClinicalTrsil.giv
https://clinicaltrials.gov/ct2/results?cond=Glaucoma&term=ni...
Results are promising, but like most therapeutics the efficacy is likely to vary by genotype, disease subtype, age, diet etc.
I’ve been taking 3 g/day for 6 years and have noticed improvements in cognitive function (recall, speech speed). But I freely admit that this could be placebo effect or due to weight loss and more exercise, so take my n=1 uncontrolled trial with big grain of salt.
Does it affect your sleep at all? Does it matter if you take it in the morning/night?
Do you only benefit from the high dose? Do you take 3 grams all at once, or with meals?
I just started taking it given advice from experts in glaucoma. This vitamin has great safety profile even at 5 g/day oral. But source it carefully from reputable manufacturer.
Yes, initially my sleep improved. I do not take before sleeping.
Not critical: My typical pattern when at home is 1 gm x 3 time points spread through day, but it shouldn’t matter much. No adverse GI symptoms in 6 years.
Do you have citation specific for B3?
Similar to egg freezing having greater efficacy when women aren’t thinking about egg freezing
Anybody have thoughts on that?
I recently heard about using gene therapy to cure sickle cell anemia.
Might be a good hedge, but I bet there will be ways to treat age related diseases well soon. Of course you’d have to be filthy rich or be a test subject to get it.
Too late for me but it looks an interesting idea enabling to boost organs later in life.
“Because a loss of retinal ganglion cells leads to sight loss in many conditions including inherited optic neuropathies and glaucoma, we are excited that this potential therapeutic approach could provide benefit to many patients in the future,”
Still cool, but just FYI. This is very early still.
For free!
-- Smash Mouth